Related Experiment Videos
Myelin basic protein as a possible marker for oligodendroglioma
J Tanaka1, Y Hokama, H Nakamura
1Institute of Neurological Sciences, Tottori University School of Medicine, Yonago, Japan.
Abstract:
To search for a marker for oligodendroglioma, immunohistochemical analysis of myelin basic protein (MBP) and glial fibrillary acidic protein (GFAP) were performed on tissues from 38 oligodendrogliomas. MBP was detected in 14 such tumors, positive cells being characterized by having rather rich cytoplasm containing a large nucleus and a prominent nucleolus. They seemed to be relatively poorly differentiated cells corresponding to oligodendroglioma grade II in the WHO classification, and appeared to have some cytological resemblance to immature oligodendrocytes in the newborn brain. Mature grade I tumor cells with a small dark nucleus and a perinuclear halo, and grade III anaplastic cells were MBP-negative. GFAP-positive cells were also found in tumors containing MBP-positive cells. A double immunostain for MBP and GFAP demonstrated that some tumor cells were simultaneously stained with both. Presumably the oligodendroglioma cells that showed such dual immunostaining would intrinsically express a myelin-forming glial phenotype. MBP may be applicable as a marker for oligodendrogliomas.
Insights
Myelin basic protein (MBP) can serve as a marker for oligodendroglioma. Immunohistochemical analysis found MBP in some tumors, potentially indicating a myelin-forming glial phenotype in cancer cells.
Area of Science:
- Neuro-oncology
- Immunohistochemistry
- Molecular Pathology
Background:
- Oligodendrogliomas are primary brain tumors arising from oligodendrocytes.
- Accurate diagnosis and subtyping of oligodendrogliomas are crucial for prognosis and treatment.
- Identifying specific cellular markers can aid in tumor classification.
Purpose of the Study:
- To investigate the utility of myelin basic protein (MBP) and glial fibrillary acidic protein (GFAP) as immunohistochemical markers for oligodendroglioma.
- To correlate the expression of MBP and GFAP with tumor grade and cellular morphology.
Main Methods:
- Immunohistochemical analysis of MBP and GFAP was performed on 38 oligodendroglioma tissue samples.
- Double immunostaining was utilized to assess co-expression of MBP and GFAP in tumor cells.
- Tumor grading was based on the WHO classification system.
Main Results:
- Myelin basic protein (MBP) was detected in 14 out of 38 oligodendrogliomas, primarily in poorly differentiated (WHO grade II) tumors.
- MBP-positive cells exhibited characteristics resembling immature oligodendrocytes.
- Glial fibrillary acidic protein (GFAP) was also found in some tumors, with some cells showing co-expression of both MBP and GFAP.
- Mature (grade I) and anaplastic (grade III) oligodendroglioma cells were MBP-negative.
Conclusions:
- Myelin basic protein (MBP) shows promise as a specific marker for a subset of oligodendrogliomas, particularly those with features of immaturity.
- Co-expression of MBP and GFAP suggests an intrinsic myelin-forming glial phenotype in some oligodendroglioma cells.
- MBP immunohistochemistry can be a valuable tool in the diagnostic evaluation of oligodendroglioma.